Literature DB >> 10328986

Novel mechanisms of estrogen action in the brain: new players in an old story.

C D Toran-Allerand1, M Singh, G Sétáló.   

Abstract

Estrogen elicits a selective enhancement of the growth and differentiation of axons and dendrites (neurites) in the developing brain. Widespread colocalization of estrogen and neurotrophin receptors (trk) within estrogen and neurotrophin targets, including neurons of the cerebral cortex, sensory ganglia, and PC12 cells, has been shown to result in differential and reciprocal transcriptional regulation of these receptors by their ligands. In addition, estrogen and neurotrophin receptor coexpression leads to convergence or cross-coupling of their signaling pathways, particularly at the level of the mitogen-activated protein (MAP) kinase cascade. 17beta-Estradiol elicits rapid (within 5-15 min) and sustained (at least 2 h) tyrosine phosphorylation and activation of the MAP kinases, extracellular-signal regulated kinase (ERK)1, and ERK2, which is successfully inhibited by the MAP kinase/ERK kinase 1 inhibitor PD98059, but not by the estrogen receptor (ER) antagonist ICI 182,780 and also does not appear to result from estradiol-induced activation of trk. Furthermore, the ability of estradiol to phosphorylate ERK persists even in ER-alpha knockout mice, implicating other estrogen receptors such as ER-beta in these actions of estradiol. The existence of an estrogen receptor-containing, multimeric complex consisting of hsp90, src, and B-Raf also suggests a direct link between the estrogen receptor and the MAP kinase signaling cascade. Collectively, these novel findings, coupled with our growing understanding of additional signaling substrates utilized by estrogen, provide alternative mechanisms for estrogen action in the developing brain which could explain not only some of the very rapid effects of estrogen, but also the ability of estrogen and neurotrophins to regulate the same broad array of cytoskeletal and growth-associated genes involved in neurite growth and differentiation. This review expands the usually restrictive view of estrogen action in the brain beyond the confines of sexual differentiation and reproductive neuroendocrine function. It considers the much broader question of estrogen as a neural growth factor with important influences on the development, survival, plasticity, regeneration, and aging of the mammalian brain and supports the view that the estrogen receptor is not only a ligand-induced transcriptional enhancer but also a mediator of rapid, nongenomic events. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328986     DOI: 10.1006/frne.1999.0177

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  91 in total

1.  Target-dependent sexual differentiation of a limbic-hypothalamic neural pathway.

Authors:  M A Ibanez; G Gu; R B Simerly
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 2.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

3.  Estrogen-dependent transcription of the NEL-like 2 (NELL2) gene and its role in protection from cell death.

Authors:  Eun Jung Choi; Dong Hee Kim; Jae Geun Kim; Dong Yeol Kim; Jung Dae Kim; Ok Ju Seol; Choon Soo Jeong; Jeong Woo Park; Min Young Choi; Sung Goo Kang; Maria E Costa; Sergio R Ojeda; Byung Ju Lee
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

4.  Effects of early visual experience and diurnal rhythms on BDNF mRNA and protein levels in the visual system, hippocampus, and cerebellum.

Authors:  G S Pollock; E Vernon; M E Forbes; Q Yan; Y T Ma; T Hsieh; R Robichon; D O Frost; J E Johnson
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

5.  Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites.

Authors:  Vladimir Znamensky; Keith T Akama; Bruce S McEwen; Teresa A Milner
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 6.  Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?

Authors:  Rachel Saunders-Pullman
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 7.  Mechanisms of dendritic maturation.

Authors:  Frederic Libersat; Carsten Duch
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

8.  Suppression subtractive hybridization and microarray identification of estrogen-regulated hypothalamic genes.

Authors:  Anna Malyala; Patrick Pattee; Srinivasa R Nagalla; Martin J Kelly; Oline K Rønnekleiv
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 9.  Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Front Neuroendocrinol       Date:  2012-10-02       Impact factor: 8.606

10.  Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1.

Authors:  Chunhe Wang; Babak Dehghani; Yuexin Li; Laurie J Kaler; Thomas Proctor; Arthur A Vandenbark; Halina Offner
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.